{
  "questions": [
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "orofacial edema, recurrent facial paralysis and lingua plicata"
        ],
        [
          "recurrent facial paralysis"
        ],
        [
          "relapsing facial paralysis"
        ],
        [
          "orofacial swelling"
        ],
        [
          "fissured tongue."
        ],
        [
          "facial swelling, recurrent facial nerve palsy and fissured tongue."
        ],
        [
          "orofacial edema, recurrent facial paralysis and lingua plicata."
        ],
        [
          "persistent or recurrent orofacial edema, relapsing facial paralysis and fissured tongue"
        ],
        [
          "persistent or recurrent orofacial edema, relapsing facial paralysis and fissured tongue."
        ],
        [
          "persistent or recurrent orofacial edema"
        ],
        [
          "facial paralysis, orofacial swelling, and fissured tongue"
        ],
        [
          "triad of relapsing facial paralysis, orofacial swelling, and fissured tongue"
        ],
        [
          "the classic triad of facial swelling, recurrent facial nerve palsy and fissured tongue"
        ],
        [
          "facial nerve palsy, lip swelling, and fissured or furrowed tongue"
        ],
        [
          "relapsing facial paralysis,"
        ],
        [
          "the triad of relapsing facial paralysis, orofacial swelling, and fissured tongue"
        ],
        [
          "facial swelling"
        ],
        [
          "triad of facial swelling, recurrent facial nerve palsy and fissured tongue"
        ],
        [
          "relapsing facial paralysis"
        ],
        [
          "facial swelling, recurrent facial nerve palsy"
        ]
      ],
      "id": "5c6f14297c78d69471000052"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "MS Amanda"
        ],
        [
          "OMSSA"
        ],
        [
          "MyriMatch"
        ],
        [
          "Comet"
        ],
        [
          "Andromeda"
        ],
        [
          "Tide"
        ],
        [
          "X!Tandem, MS-GF[Formula: see text]"
        ],
        [
          "MS Amanda, MyriMatch,"
        ],
        [
          "MS Amanda,"
        ],
        [
          "X!Tandem, MS-GF"
        ],
        [
          "X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet, Tide,"
        ],
        [
          "(X!Tandem, MS-GF[Formula: see text],"
        ],
        [
          "(X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch,"
        ],
        [
          "X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch"
        ],
        [
          "X!Tandem, MS-GF[Formula: see text], MS Amanda"
        ],
        [
          "X!Tandem,"
        ],
        [
          "MyriMatch, Comet, Tide, Andromeda, and OMSSA"
        ],
        [
          "MaxQuant, Proteome Discoverer, or Mascot"
        ],
        [
          "(X!Tandem, MS-GF[Formula: see text], MS Amanda,"
        ],
        [
          "X!Tandem, MS-GF[Formula: see text], MS Amanda, MyriMatch, Comet,"
        ]
      ],
      "id": "5c78174b7c78d694710000b1"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "dysfunctions of one of genes coding for lysosomal enzymes involved in degradation of heparan sulfate"
        ],
        [
          "MPS IIID"
        ],
        [
          "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA,"
        ],
        [
          "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA"
        ],
        [
          "dysfunctions"
        ],
        [
          "MPS IIIA"
        ],
        [
          "MPS IIIB,"
        ],
        [
          "MPS IIIC"
        ],
        [
          "MPS IIID."
        ],
        [
          "MPS IIIA, MPS IIIB, MPS IIIC and MPS IIID."
        ],
        [
          "NAGLU (coding for alpha-N-acetylglucosaminidase) - causing MPS IIIB,"
        ],
        [
          "MPS IIIB,"
        ],
        [
          "SGSH"
        ],
        [
          "mucopolysaccharidosis type III, MPS III"
        ],
        [
          "caused by dysfunctions of one of genes coding for lysosomal enzymes involved in degradation of heparan sulfate"
        ],
        [
          "MPS III"
        ],
        [
          "MPS IIIC and MPS IIID"
        ],
        [
          "dysfunctions of one of genes coding for lysosomal enzymes involved in degradation of heparan sulfate:"
        ],
        [
          "MPS IIIB, MPS IIIC and MPS IIID"
        ],
        [
          "GNS (coding for N-acetylglucosamine-6-sulfatase) - causing MPS IIID"
        ]
      ],
      "id": "5c6ffa257c78d69471000056"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "CD63"
        ],
        [
          "Rab7."
        ],
        [
          "mannose-6-phosphate receptor (M6PR)"
        ],
        [
          "early endosome antigen 1"
        ],
        [
          "mannose-6-phosphate receptor (M6PR) and Rab7"
        ],
        [
          "CD63"
        ],
        [
          "early phagosomal marker early endosome antigen 1"
        ],
        [
          "Rab7, Lysosomal Associated Membrane Protein 1,"
        ],
        [
          "Rab7"
        ],
        [
          "late phagosomal markers CD63 and Rab7."
        ],
        [
          "Rab7,"
        ],
        [
          "7"
        ],
        [
          "they could nevertheless acquire the late phagosomal markers CD63 and Rab7"
        ],
        [
          "early endosome antigen 1 colocalized with all isolates tested"
        ],
        [
          "the late phagosomal markers CD63 and Rab7"
        ],
        [
          "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase"
        ],
        [
          "markers CD63 and Rab7"
        ],
        [
          "the early phagosomal marker early endosome antigen 1"
        ],
        [
          "early endosome antigen 1 colocalized with all isolates tested,"
        ],
        [
          "marker early endosome antigen 1"
        ]
      ],
      "id": "5c76e6d27c78d694710000ac"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "Methods have been developed that use weighted allocation of read counts"
        ],
        [
          "weighted allocation of read counts"
        ],
        [
          "Methods that align RNA-seq reads to a diploid transcriptome incorporating known genetic variants"
        ],
        [
          "Weighted allocation methods"
        ],
        [
          "Methods have been developed that use weighted allocation of read counts but these methods treat the different types of multi-reads equivalently."
        ],
        [
          "developed that use weighted allocation of read counts"
        ],
        [
          "use weighted allocation of read counts"
        ],
        [
          "Methods have been developed that use weighted allocation"
        ],
        [
          "Methods that align RNA-seq reads to a diploid transcriptome"
        ],
        [
          "Methods have been developed that use weighted allocation of read counts but these methods treat the different types of multi-reads equivalently"
        ],
        [
          "have been developed that use weighted allocation of read counts"
        ],
        [
          "weighted allocation of read counts but these methods treat the different types of multi-reads equivalently."
        ],
        [
          "htseq-count and featureCounts"
        ],
        [
          "weighted allocation"
        ],
        [
          "Weighted allocation"
        ],
        [
          "methods treat the different types of multi-reads equivalently."
        ],
        [
          "weighted allocation of read counts but these methods treat the different types of multi-reads equivalently. We propose a hierarchical approach"
        ],
        [
          "weighted allocation of read counts but these methods treat the different types of multi-reads equivalently"
        ],
        [
          "Weighted allocation methods outperform methods that discard multi-reads"
        ],
        [
          "htseq-count and featureCounts that handles multi-mapping reads in an unabiased way."
        ]
      ],
      "id": "5c58282e07647bbc4b00001e"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "open radical cystectomy (ORC)"
        ],
        [
          "robot-assisted RC (RARC)"
        ],
        [
          "robot-assisted RC (RARC)"
        ],
        [
          "pelvic lymph node dissection (PLND)"
        ],
        [
          "urinary diversion"
        ],
        [
          "ORC vs RARC, PLND and urinary diversion"
        ],
        [
          "RARC, PLND and urinary diversion"
        ],
        [
          "open cystectomy and robot-assisted cystectomy"
        ],
        [
          "open radical cystectomy (ORC) vs robot-assisted RC (RARC),"
        ],
        [
          "pelvic lymph node dissection (PLND) and urinary diversion"
        ],
        [
          "robot-assisted RC (RARC)"
        ],
        [
          "open radical cystectomy (ORC) vs robot-assisted RC"
        ],
        [
          "(RARC), pelvic lymph node dissection (PLND) and urinary diversion"
        ],
        [
          "robot-assisted RC (RARC),"
        ],
        [
          "ORC vs RARC, PLND and urinary diversion."
        ],
        [
          "open radical cystectomy"
        ],
        [
          "robot-assisted RC"
        ],
        [
          "ORC vs RARC"
        ],
        [
          "RARC, PLND and urinary diversion."
        ],
        [
          "open radical cystectomy (ORC)"
        ]
      ],
      "id": "5c7036127c78d69471000064"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "Fak-mediated cell migration"
        ],
        [
          "invasion"
        ],
        [
          "cell migration"
        ],
        [
          "invasion"
        ],
        [
          "focal adhesion kinase (FAK)"
        ],
        [
          "proline-rich tyrosine kinase-2 (Pyk2)"
        ],
        [
          "Fak activation as well as Fak-mediated cell migration and invasion"
        ],
        [
          "focal adhesion kinase (FAK) and proline-rich tyrosine kinase-2"
        ],
        [
          "proline-rich tyrosine kinase-2 (Pyk2)"
        ],
        [
          "PF-562271"
        ],
        [
          "focal adhesion kinase (FAK) and proline-rich tyrosine kinase-2 (Pyk2)."
        ],
        [
          "(FAK) and proline-rich tyrosine kinase-2 (Pyk2)"
        ],
        [
          "proline-rich tyrosine kinase-2"
        ],
        [
          "integrins"
        ],
        [
          "Fak-mediated cell migration and invasion."
        ],
        [
          "integrins with FAK inhibitors"
        ],
        [
          "migration and invasion"
        ],
        [
          "(FAK) and proline-rich tyrosine kinase-2"
        ],
        [
          "cell migration and invasion."
        ],
        [
          "second-generation inhibitor of focal adhesion kinase (FAK) and proline-rich tyrosine kinase-2 (Pyk2)"
        ]
      ],
      "id": "5c6f107c7c78d69471000051"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "gene-specific bias"
        ],
        [
          "By explicitly identifying the reasons for gene-specific bias"
        ],
        [
          "explicitly identifying the reasons for gene-specific bias"
        ],
        [
          "reasons for gene-specific bias"
        ],
        [
          "gene-specific bias"
        ],
        [
          "performing a meta-analysis of existing computational"
        ],
        [
          "experimental knowledge bases"
        ],
        [
          "explicitly identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases"
        ],
        [
          "identifying the reasons for gene-specific bias"
        ],
        [
          "reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases"
        ],
        [
          "gene-specific strategies for the identification of important but hitherto ignored genes that can open novel directions for future investigation."
        ],
        [
          "gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases,"
        ],
        [
          "the reasons for gene-specific bias"
        ],
        [
          "identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases"
        ],
        [
          "By explicitly identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases,"
        ],
        [
          "we describe gene-specific strategies for the identification of important but hitherto ignored genes that can open novel directions for future investigation."
        ],
        [
          "explicitly identifying the reasons for gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases,"
        ],
        [
          "gene-specific strategies for the identification of important but hitherto ignored genes"
        ],
        [
          "gene-specific strategies for the identification of important but hitherto ignored genes that can open novel directions for future investigation"
        ],
        [
          "gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases, we describe gene-specific strategies"
        ]
      ],
      "id": "5c5214207e3cb0e231000003"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "UPDtool"
        ],
        [
          "trio SNP-microarray experiments"
        ],
        [
          "UPDtool is a computational tool"
        ],
        [
          "trio SNP-microarray experiments."
        ],
        [
          "SNP-microarray experiments"
        ],
        [
          "UPDtool is a computational tool for detection and classification"
        ],
        [
          "UPDtool is a computational tool for detection and classification of uniparental disomy (UPD) in trio"
        ],
        [
          "in trio SNP-microarray experiments"
        ],
        [
          "detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments"
        ],
        [
          "computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments"
        ],
        [
          "UPDtool is a computational tool for detection and classification of uniparental disomy"
        ],
        [
          "a computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments"
        ],
        [
          "SNP-microarray experiments."
        ],
        [
          "UPDtool is a computational tool for detection and classification of uniparental disomy (UPD) in trio SNP"
        ],
        [
          "in trio SNP-microarray experiments."
        ],
        [
          "classification of uniparental disomy (UPD) in trio SNP-microarray experiments"
        ],
        [
          "is a computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments"
        ],
        [
          "detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments."
        ],
        [
          "computational tool for detection and classification of uniparental disomy (UPD) in trio SNP-microarray experiments."
        ],
        [
          "trio SNP-microarray"
        ]
      ],
      "id": "5c544c1707647bbc4b000003"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "DNMT3A"
        ],
        [
          "PRKCD"
        ],
        [
          "C1QTNF4"
        ],
        [
          "missense de novo mutations (DNM)"
        ],
        [
          "missense de novo mutations (DNM"
        ],
        [
          "missense"
        ],
        [
          "missense de novo mutations"
        ],
        [
          "DNM)"
        ],
        [
          "(DNM), none of which are within the &gt;80 SLE susceptibility loci"
        ],
        [
          "DNM"
        ],
        [
          "(DNM)"
        ],
        [
          "missense de novo mutations (DNM), none of which are within the &gt;80"
        ],
        [
          "missense de novo mutations (DNM), none of which are within the &gt;80 SLE"
        ],
        [
          "(DNM"
        ],
        [
          "DNMT3A, PRKCD, and C1QTNF4."
        ],
        [
          "none of which are within the &gt;80 SLE susceptibility loci"
        ],
        [
          "14 genes with missense de novo mutations (DNM)"
        ],
        [
          "missense de novo mutations (DNM),"
        ],
        [
          "14 genes with missense de novo mutations (DNM"
        ],
        [
          "(DNM), none of which are within the &gt;80"
        ]
      ],
      "id": "5c62a276e842deac6700000a"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "acts at the midbody"
        ],
        [
          "the structure where abscission occurs at the end of cytokinesis"
        ],
        [
          "genetically interacts with slx-1 and mus-81 mutants"
        ],
        [
          "mus-81 mutants"
        ],
        [
          "depends on factors needed for midbody assembly"
        ],
        [
          "LEM-3 localization depends on factors needed for midbody assembly"
        ],
        [
          "LEM-3 acts at the midbody, the structure where abscission occurs at the end of cytokinesis"
        ],
        [
          "localization depends on factors needed for midbody assembly"
        ],
        [
          "factors needed for midbody assembly"
        ],
        [
          "acts at the midbody"
        ],
        [
          "genetically interacts with slx-1 and mus-81"
        ],
        [
          "Proper LEM-3 midbody localization and function is regulated by AIR-2/Aurora B kinase"
        ],
        [
          "process erroneous recombination intermediates that persist into the second meiotic division"
        ],
        [
          "acts at the midbody, the structure where abscission occurs at the end of cytokinesis."
        ],
        [
          "factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged when chromatin bridges are trapped at the cleavage plane"
        ],
        [
          "regulated by AIR-2/Aurora B kinase"
        ],
        [
          "depends on factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged"
        ],
        [
          "process erroneous recombination intermediates that persist into the second meiotic division."
        ],
        [
          "LEM-3 localization depends on factors needed for midbody assembly, and LEM-3 accumulation is increased and prolonged"
        ],
        [
          "accumulation is increased and prolonged when chromatin bridges are trapped at the cleavage plane"
        ]
      ],
      "id": "5c54224807647bbc4b000001"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "combined checkpoint inhibitors"
        ],
        [
          "combined checkpoint inhibitors compared to sunitinib"
        ],
        [
          "checkpoint inhibitors"
        ],
        [
          "superior overall survival and objective response with combined checkpoint inhibitors"
        ],
        [
          "inhibitors"
        ],
        [
          "combined"
        ],
        [
          "sunitinib"
        ],
        [
          "demonstrated superior overall survival and objective response with combined checkpoint inhibitors"
        ],
        [
          "objective response with combined checkpoint inhibitors"
        ],
        [
          "s"
        ],
        [
          "combined checkpoint inhibitors compared to sunitinib in Treatment-Naïve Advanced RCC among intermediate- and poor-risk group"
        ],
        [
          "with combined checkpoint inhibitors"
        ],
        [
          "phase III trial, demonstrated superior overall survival and objective response with combined checkpoint inhibitors"
        ],
        [
          "CheckMate 214, a phase III trial, demonstrated superior overall survival and objective response with combined checkpoint inhibitors"
        ],
        [
          "checkpoint inhibitors compared to sunitinib"
        ],
        [
          "superior overall survival and objective response with combined checkpoint inhibitors compared to sunitinib"
        ],
        [
          "inhibitors compared to sunitinib"
        ],
        [
          "combined immunotherapy with nivolumab plus ipilimumab"
        ],
        [
          "combined checkpoint inhibitors compared to sunitinib in Treatment-Naïve Advanced RCC"
        ],
        [
          "combined checkpoint inhibitors compared to sunitinib in Treatment-Naïve Advanced RCC among intermediate- and poor-risk"
        ]
      ],
      "id": "5c6dfdf27c78d69471000047"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "ITGA4 and ITGB8"
        ],
        [
          "ITGB8"
        ],
        [
          "(ITGA4 and ITGB8"
        ],
        [
          "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1"
        ],
        [
          "ITGA4"
        ],
        [
          "8"
        ],
        [
          "ITGB8"
        ],
        [
          "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1)"
        ],
        [
          "ITGA4 and ITGB8)"
        ],
        [
          "two of these genes (ITGA4 and ITGB8"
        ],
        [
          "IT"
        ],
        [
          "4 and ITGB8"
        ],
        [
          "expression changes in response to immune stimulus at two of these genes (ITGA4 and ITGB8"
        ],
        [
          "ITGA4 and ITGB8) and at previously implicated loci (ITGAL"
        ],
        [
          "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1)."
        ],
        [
          "ITGA4 and"
        ],
        [
          "ITGA4 and ITGB"
        ],
        [
          "associated variants are correlated with expression changes in response to immune stimulus at two of these genes (ITGA4 and ITGB8"
        ],
        [
          "The associated variants are correlated with expression changes in response to immune stimulus at two of these genes (ITGA4 and ITGB8"
        ],
        [
          "(ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1"
        ]
      ],
      "id": "5c596ad686df2b9174000015"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "phosphoinositide-3-kinase (PI3K)-δ"
        ],
        [
          "-γ"
        ],
        [
          "phospho-AKT (S473)"
        ],
        [
          "phospho-AKT"
        ],
        [
          "PI3K)-δ and -γ"
        ],
        [
          "(PI3K)-δ and -γ"
        ],
        [
          "phospho-AKT (S473) in CLL tumor cells"
        ],
        [
          "PI3Kγ and PI3Kδ"
        ],
        [
          "phosphoinositide 3-kinase-δ (PI3K-δ) and PI3K-γ"
        ],
        [
          "phosphoinositide-3-kinase (PI3K)-δ and -γ,"
        ],
        [
          "inhibition of phospho-AKT (S473)"
        ],
        [
          "inhibition of phospho-AKT"
        ],
        [
          "AKT (S473)"
        ],
        [
          "AKT"
        ],
        [
          "kinase (PI3K)-δ and -γ"
        ],
        [
          "phosphatidylinositol 3-kinase (PI3K)-δ/γ isoforms"
        ],
        [
          "phospho-AKT (S473"
        ],
        [
          "PI3K)-δ and -γ,"
        ],
        [
          "phospho-AKT (S473) in CLL"
        ],
        [
          "phosphoinositide-3-kinase"
        ]
      ],
      "id": "5c72b6be7c78d69471000072"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "prophylaxis of cytomegalovirus infection"
        ],
        [
          "disease after stem cell transplant"
        ],
        [
          "human cytomegalovirus infection treatment"
        ],
        [
          "prophylaxis"
        ],
        [
          "prophylaxis of cytomegalovirus infection and disease"
        ],
        [
          "prophylaxis of cytomegalovirus infection and disease after stem cell transplant;"
        ],
        [
          "orally or intravenously"
        ],
        [
          "cytomegalovirus infection treatment and prophylaxis"
        ],
        [
          "cytomegalovirus infection and disease after stem cell transplant"
        ],
        [
          "orally or intravenously administered"
        ],
        [
          "treatment and prophylaxis"
        ],
        [
          "for prophylaxis of cytomegalovirus infection and disease after stem cell transplant"
        ],
        [
          "human cytomegalovirus infection treatment and prophylaxis."
        ],
        [
          "cytomegalovirus infection and disease"
        ],
        [
          "cytomegalovirus infection and disease after stem cell transplant;"
        ],
        [
          "for prophylaxis of cytomegalovirus infection and disease"
        ],
        [
          "for prophylaxis of cytomegalovirus infection and disease after stem cell transplant;"
        ],
        [
          "prophylaxis"
        ],
        [
          "prophylaxis of cytomegalovirus infection and disease after stem cell transplant; benralizumab"
        ],
        [
          "for human cytomegalovirus infection treatment and prophylaxis"
        ]
      ],
      "id": "5c6e01af7c78d69471000048"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "inflammatory"
        ],
        [
          "metabolic"
        ],
        [
          "inflammation"
        ],
        [
          "metabolism"
        ],
        [
          "inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues"
        ],
        [
          "integration of inflammatory and metabolic"
        ],
        [
          "inflammatory and metabolic signals"
        ],
        [
          "inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic"
        ],
        [
          "nutritional and metabolic cues"
        ],
        [
          "integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues"
        ],
        [
          "inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues."
        ],
        [
          "nutritional and metabolic"
        ],
        [
          "integration of inflammatory and metabolic signals"
        ],
        [
          "integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic"
        ],
        [
          "nutritional and metabolic cues."
        ],
        [
          "integration of inflammatory and metabolic signals in adipose tissue where it is highly expressed and regulated by nutritional and metabolic cues."
        ],
        [
          "inflammation"
        ],
        [
          "metabolic"
        ],
        [
          "inflammation and metabolism in adipocytes. Lack of STAMP2 in adipocytes results in aberrant inflammatory responses"
        ],
        [
          "metabolism"
        ]
      ],
      "id": "5c57041807647bbc4b000015"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "dolutegravir (DTG)"
        ],
        [
          "lamivudine (3TC)"
        ],
        [
          "abacavir (ABC)"
        ],
        [
          "tenofovir"
        ],
        [
          "emtricitabine"
        ],
        [
          "elvitegravir"
        ],
        [
          "cobicistat"
        ],
        [
          "Newer STRs"
        ],
        [
          "Many single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets"
        ],
        [
          "single-tablet regimens (STRs), including newer fixed-dose combination (FDC) tablets"
        ],
        [
          "fixed-dose combination (FDC) tablets"
        ],
        [
          "dolutegravir"
        ],
        [
          "Many single-tablet regimens (STRs"
        ],
        [
          "single-tablet regimens (STRs"
        ],
        [
          "newer fixed-dose combination (FDC) tablets"
        ],
        [
          "Many single-tablet regimens"
        ],
        [
          "(tenofovir, emtricitabine, elvitegravir and cobicistat"
        ],
        [
          "single-tablet regimens"
        ],
        [
          "Regimen Stribild (tenofovir, emtricitabine, elvitegravir and cobicistat"
        ],
        [
          "STRs and FDCs"
        ]
      ],
      "id": "5c7034ae7c78d69471000063"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "The tmVar 2.0"
        ],
        [
          "tmVar 2.0"
        ],
        [
          "The tmVar 2.0 source code"
        ],
        [
          "zhiyong.lu@nih.gov."
        ],
        [
          "The tmVar 2.0 source code and corpus"
        ],
        [
          "corpus"
        ],
        [
          "tmVar software and its corpus of 500 manually curated abstracts are available for download"
        ],
        [
          "2.0"
        ],
        [
          "The tmVar"
        ],
        [
          "zhiyong.lu@nih.gov"
        ],
        [
          "tmVar 2.0 source code"
        ],
        [
          "tmvar/.zhiyong.lu@nih.gov."
        ],
        [
          "source code"
        ],
        [
          "available for download"
        ],
        [
          "ClinVar"
        ],
        [
          "Tools/tmvar/.zhiyong.lu@nih.gov."
        ],
        [
          "software and its corpus of 500 manually curated abstracts are available for download"
        ],
        [
          "."
        ],
        [
          "500 manually curated abstracts are available for download"
        ],
        [
          "tmvar/.zhiyong.lu@nih.gov"
        ]
      ],
      "id": "5c561da707647bbc4b00000f"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "Gram-positive"
        ],
        [
          "Gram-negative"
        ],
        [
          "Gram-positive and Gram-negative bacteria"
        ],
        [
          "Streptococcus pneumoniae."
        ],
        [
          "Staphylococcus aureus"
        ],
        [
          "Klebsiella pneumoniae"
        ],
        [
          "Gram-negative bacteria"
        ],
        [
          "a broad range of Gram-positive and Gram-negative"
        ],
        [
          "negative"
        ],
        [
          "positive and Gram-negative"
        ],
        [
          "Gram-positive"
        ],
        [
          "Gram-negative bacteria."
        ],
        [
          "Gram"
        ],
        [
          "Gram-positive and Gram"
        ],
        [
          "active against a broad range of Gram-positive and Gram-negative"
        ],
        [
          "broad range of Gram-positive and Gram-negative bacteria"
        ],
        [
          "Gram-positive and Gram-negative bacteria. In this study, 200 Streptococcus pneumoniae"
        ],
        [
          "a broad range of Gram-positive and Gram-negative bacteria"
        ],
        [
          "-positive and Gram-negative"
        ],
        [
          "Klebsiella pneumoniae"
        ]
      ],
      "id": "5c0119f3133db5eb7800002b"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "dimethylxanthenone-4-acetic acid (DMXAA)"
        ],
        [
          "dimethylxanthenone-4-acetic acid (DMXAA"
        ],
        [
          "dimethylxanthenone-4-acetic acid"
        ],
        [
          "dimethylxanthenone-4-acetic acid (DMXAA)."
        ],
        [
          "DMXAA)"
        ],
        [
          "DMXAA"
        ],
        [
          "DMXAA)."
        ],
        [
          "(DMXAA)"
        ],
        [
          "(DMXAA"
        ],
        [
          "dimethylxanthenone-4-acetic acid ("
        ],
        [
          "a STING agonist, dimethylxanthenone-4-acetic acid (DMXAA)"
        ],
        [
          "dim"
        ],
        [
          "dimethylxanthenone-4-acetic acid (D"
        ],
        [
          "a STING agonist, dimethylxanthenone-4-acetic acid (DMXAA"
        ],
        [
          "a STING agonist, dimethylxanthenone-4-acetic acid"
        ],
        [
          "(DMXAA)."
        ],
        [
          "STING agonist, dimethylxanthenone-4-acetic acid (DMXAA)"
        ],
        [
          "dimethylxanthenone-4-acetic acid (DMX"
        ],
        [
          "agonist, dimethylxanthenone-4-acetic acid (DMXAA)"
        ],
        [
          "STING agonist, dimethylxanthenone-4-acetic acid (DMXAA"
        ]
      ],
      "id": "5c7ab080d774d0424000000b"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "Trifluridine"
        ],
        [
          "tipiracil"
        ],
        [
          "Trifluridine/tipiracil (TAS-102"
        ],
        [
          "Trifluridine/tipiracil (TAS-102, Lonsurf®)"
        ],
        [
          "Trifluridine/tipiracil (TAS-102, Lonsurf®"
        ],
        [
          "Tri"
        ],
        [
          "Trifluridine/tipiracil (TAS-102,"
        ],
        [
          "l"
        ],
        [
          "Trifluridine/tipiracil (TAS-102, Lonsurf®),"
        ],
        [
          "Trifluridine/tipiracil (TAS-102, Lonsurf®), a novel oral anti-tumor agent"
        ],
        [
          "Trifluridine"
        ],
        [
          "trifluridine/tipiracil (TAS-102, Lonsurf®)"
        ],
        [
          "tipiracil"
        ],
        [
          "trifluridine/tipiracil (TAS-102, Lonsurf®), an antimetabolite"
        ],
        [
          "ine/tipiracil"
        ],
        [
          "trifluridine and tipiracil"
        ],
        [
          "trifluridine"
        ],
        [
          "trifluridine/tipiracil (TAS-102, Lonsurf®),"
        ],
        [
          "trifluridine/tipiracil (TAS-102"
        ],
        [
          "such as trifluridine/tipiracil"
        ]
      ],
      "id": "5c72a9147c78d6947100006e"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "deep genetic"
        ],
        [
          "phenotypic"
        ],
        [
          "phenotypic data"
        ],
        [
          "deep genetic and phenotypic data"
        ],
        [
          "genetic and phenotypic"
        ],
        [
          "genetic and phenotypic data"
        ],
        [
          "phenotypic"
        ],
        [
          "deep genetic"
        ],
        [
          "phenotypic data"
        ],
        [
          "genetic"
        ],
        [
          "phenotypic and health-related information"
        ],
        [
          "deep genetic and phenotypic data collected on approximately 500,000 individuals"
        ],
        [
          "deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom"
        ],
        [
          "deep"
        ],
        [
          "genetic and phenotypic data collected on approximately 500,000 individuals"
        ],
        [
          "data"
        ],
        [
          "genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom"
        ],
        [
          "deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69 at recruitment."
        ],
        [
          "phenotypic and health-related information is available on each participant"
        ],
        [
          "deep genetic and phenotypic data collected on approximately 500,000 individuals from across the United Kingdom, aged between 40 and 69"
        ]
      ],
      "id": "5c5205137e3cb0e231000001"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "telangiectasias"
        ],
        [
          "monoclonal gammopathy"
        ],
        [
          "elevated erythropoietin level"
        ],
        [
          "perinephric fluid collections"
        ],
        [
          "intrapulmonary shunting"
        ],
        [
          "telangiectasias,"
        ],
        [
          "elevated erythropoietin level and erythrocytosis,"
        ],
        [
          "monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting)"
        ],
        [
          "telangiectasias, erythrocytosis with elevated erythropoietin"
        ],
        [
          "te"
        ],
        [
          "telangiectasias"
        ],
        [
          "(telangiectasias,"
        ],
        [
          "perinephric fluid collections, and intrapulmonary shunting"
        ],
        [
          "elevated erythropoietin level and erythrocytosis"
        ],
        [
          "elevated erythropoietin and normal vascular endothelial growth factor level"
        ],
        [
          "intrapulmonary shunting"
        ],
        [
          "telangiectasias, elevated"
        ],
        [
          "telangiectasias, erythrocytosis with elevated erythropoietin,"
        ],
        [
          "monoclonal gammopathy,"
        ],
        [
          ", monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting"
        ]
      ],
      "id": "5c6b7daa7c78d6947100002b"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "primarily target standard (ST) mutation mentions"
        ],
        [
          "target standard (ST) mutation mentions"
        ],
        [
          "primarily target standard (ST) mutation mentions (e.g. 'E6V')"
        ],
        [
          "target standard (ST) mutation mentions (e.g. 'E6V')"
        ],
        [
          "primarily target standard (ST) mutation mentions (e.g. 'E6V'),"
        ],
        [
          "methods primarily target standard (ST) mutation mentions"
        ],
        [
          "primarily target standard (ST) mutation"
        ],
        [
          "Existing methods primarily target standard (ST) mutation mentions"
        ],
        [
          "target standard (ST) mutation mentions (e.g. 'E6V'),"
        ],
        [
          "primarily target"
        ],
        [
          "(ST) mutation mentions"
        ],
        [
          "methods primarily target standard (ST) mutation mentions (e.g. 'E6V')"
        ],
        [
          "primarily target standard"
        ],
        [
          "conditional random field (CRF)"
        ],
        [
          "target standard (ST) mutation"
        ],
        [
          "primarily"
        ],
        [
          "standard (ST) mutation mentions"
        ],
        [
          "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V')"
        ],
        [
          "automatic approaches"
        ],
        [
          "target"
        ]
      ],
      "id": "5c56bbb107647bbc4b000011"
    },
    {
      "ideal_answer": [
        "Dummy"
      ],
      "type": "list",
      "exact_answer": [
        [
          "gynecological cancers"
        ],
        [
          "gynecological cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in gynecological cancers"
        ],
        [
          "gynecological cancers remains unknown"
        ],
        [
          "human cancers remains undefined"
        ],
        [
          "the clinical significance of uc.189 in gynecological cancers"
        ],
        [
          "gynecological"
        ],
        [
          "in gynecological cancers"
        ],
        [
          "s"
        ],
        [
          "clinicopathological features"
        ],
        [
          "clinicopathological features and prognosis"
        ],
        [
          "human cancers"
        ],
        [
          "human cancers remains undefined and the clinical significance of uc.189 in esophageal cancers"
        ],
        [
          "CSCCs"
        ],
        [
          "ovarian cystoadenocarcinomas"
        ],
        [
          "116 cervical squamous cell carcinomas (CSCCs"
        ],
        [
          "advanced clinical stage (p=0.000), lymph node metastasis (p=0.000), and poor prognosis"
        ],
        [
          "unknown. This study was to identify the prognostic value of uc.189 expression in gynecological cancers"
        ],
        [
          "CSCCs), 98 endometrial adenocarcinomas (EACs)"
        ],
        [
          "cervical squamous cell carcinomas (CSCCs"
        ],
        [
          "116 cervical squamous cell carcinomas"
        ]
      ],
      "id": "5c580fe107647bbc4b00001b"
    },
    {
      "exact_answer": [
        [
          "neuronal ceroid lipofuscinosis type 2"
        ],
        [
          "neuronal ceroid lipofuscinosis type 2 (CLN2)"
        ],
        [
          "neuronal ceroid lipofuscinosis type 2 (CLN2) disease"
        ],
        [
          "neuronal ceroid lipofuscinosis"
        ],
        [
          "neuronal ceroid lipofuscinosis type 2 (CLN2"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6b810e7c78d6947100002e"
    },
    {
      "exact_answer": [
        [
          "DeepVariant"
        ],
        [
          "DeepVariant,"
        ],
        [
          "DeepVarian"
        ],
        [
          "Deep"
        ],
        [
          "t"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c51fb7a07ef653866000006"
    },
    {
      "exact_answer": [
        [
          "cystic fibrosis"
        ],
        [
          "bona fide CF"
        ],
        [
          "cystic fibrosis (CF)"
        ],
        [
          "bona fide"
        ],
        [
          "cystic fibrosis (CF"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6e16eb7c78d6947100004e"
    },
    {
      "exact_answer": [
        [
          "DSMNC"
        ],
        [
          "DSMNC:"
        ],
        [
          "DSMNC: a database of somatic mutations in normal cells"
        ],
        [
          "DS"
        ],
        [
          "DSM"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c5b268986df2b9174000019"
    },
    {
      "exact_answer": [
        [
          "calcitonin gene-related peptide receptor"
        ],
        [
          "the calcitonin gene-related peptide receptor"
        ],
        [
          "calcitonin"
        ],
        [
          "gene-related peptide receptor"
        ],
        [
          "calcitonin gene-related peptide"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c71d7ca7c78d6947100006b"
    },
    {
      "exact_answer": [
        [
          "mutations in TGM1"
        ],
        [
          "mutations in TGM1."
        ],
        [
          "mainly by mutations in TGM1"
        ],
        [
          "TGM1"
        ],
        [
          "novel mutation of the transglutaminase 1 gene (TGM1)"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c531d8f7e3cb0e231000017"
    },
    {
      "exact_answer": [
        [
          "June 2017"
        ],
        [
          "2017"
        ],
        [
          "in June 2017"
        ],
        [
          "June"
        ],
        [
          "June 2017 received approval in the USA"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c0117fd133db5eb7800002a"
    },
    {
      "exact_answer": [
        [
          "PIK3CA"
        ],
        [
          "PIK3CA gene"
        ],
        [
          "the PIK3CA"
        ],
        [
          "the PIK3CA gene"
        ],
        [
          "PIK3"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c5b4a941a4c55d80b000002"
    },
    {
      "exact_answer": [
        [
          "ALK G1202R"
        ],
        [
          "G1202R"
        ],
        [
          "ALK G1202R, the most frequent plasma mutation detected after progression on a second-generation TKI"
        ],
        [
          "ALK G1202R, the most frequent plasma mutation detected after progression on a second-generation TKI,"
        ],
        [
          "ALK G1202R,"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c72ade07c78d69471000070"
    },
    {
      "exact_answer": [
        [
          "Clostridium difficile"
        ],
        [
          "C. difficile"
        ],
        [
          "recurrent Clostridium difficile"
        ],
        [
          "Clostridium difficile,"
        ],
        [
          "Clostridium"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c71d6d27c78d6947100006a"
    },
    {
      "exact_answer": [
        [
          "CNEFinder"
        ],
        [
          "C"
        ],
        [
          "CNEFinder;"
        ],
        [
          "CNEF"
        ],
        [
          "presenting CNEFinder"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c51f01e07ef653866000002"
    },
    {
      "exact_answer": [
        [
          "defective activity of β-hexosaminidase"
        ],
        [
          "the defective activity of β-hexosaminidase"
        ],
        [
          "defective activity of β-hexosaminidase, leading to accumulation of ganglioside GM2"
        ],
        [
          "β-hexosaminidase"
        ],
        [
          "a mutation of the β-subunit gene β-hexosaminidase B (HexB)"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c78080e7c78d694710000ae"
    },
    {
      "exact_answer": [
        [
          "1 month after hepatectomy."
        ],
        [
          "(P = 0.07).Post-hepatectomy"
        ],
        [
          "just before and 1 month after hepatectomy."
        ],
        [
          "before and 1 month after hepatectomy."
        ],
        [
          "(P = 0.07).Post-hepatectomy HLs of AFP and DCP are predictors of long-term outcome"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c7839edd774d04240000003"
    },
    {
      "exact_answer": [
        [
          "copy number variation-random forest (CNV-RF)"
        ],
        [
          "CNV-RF)"
        ],
        [
          "copy number variation-random forest (CNV-RF"
        ],
        [
          "CNV-RF"
        ],
        [
          "copy number variation"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c51f9dd07ef653866000005"
    },
    {
      "exact_answer": [
        [
          "by binding to GM1"
        ],
        [
          "binding to GM1"
        ],
        [
          "by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells"
        ],
        [
          "by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface"
        ],
        [
          "can enter host cells by binding to GM1"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c7813f57c78d694710000b0"
    },
    {
      "exact_answer": [
        [
          "mogamulizumab"
        ],
        [
          "mogamulizumab,"
        ],
        [
          "m"
        ],
        [
          "mogamulizumab, a humanized anti-CCR4"
        ],
        [
          "mogamulizumab, a humanized anti-CCR4 monoclonal antibody"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c65468ce842deac6700001e"
    },
    {
      "exact_answer": [
        [
          "Capillaria hepatica"
        ],
        [
          "parasite Capillaria hepatica"
        ],
        [
          "parasite"
        ],
        [
          "parasite Capillaria hepatica,"
        ],
        [
          "the parasite Capillaria hepatica"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c571dd307647bbc4b000016"
    },
    {
      "exact_answer": [
        [
          "X-linked hypophosphatemia"
        ],
        [
          "XLH"
        ],
        [
          "hypophosphatemia"
        ],
        [
          "children with X-linked hypophosphatemia"
        ],
        [
          "X-linked"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6b7fb27c78d6947100002d"
    },
    {
      "exact_answer": [
        [
          "activation of type I interferons in response to cytosolic nucleic acid ligands"
        ],
        [
          "plays an important role in the activation of type I interferons in response to cytosolic nucleic acid ligands"
        ],
        [
          "important role in the activation of type I interferons in response to cytosolic nucleic acid ligands"
        ],
        [
          "a cytosolic sensor for cyclic dinucleotides"
        ],
        [
          "a cytosolic sensor"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c7aae9dd774d0424000000a"
    },
    {
      "exact_answer": [
        [
          "PrEP"
        ],
        [
          "supplemental indication for Truvada as PrEP"
        ],
        [
          "the supplemental indication for Truvada as PrEP"
        ],
        [
          "PrEP) and the recent approval by the FDA of the supplemental indication for Truvada as PrEP"
        ],
        [
          "Truvada as PrEP"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c5f29a81a4c55d80b00001f"
    },
    {
      "exact_answer": [
        [
          "severe rotavirus disease"
        ],
        [
          "rotavirus"
        ],
        [
          "rotavirus disease"
        ],
        [
          "severe rotavirus"
        ],
        [
          "severe"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6e05f37c78d69471000049"
    },
    {
      "exact_answer": [
        [
          "tofacitinib"
        ],
        [
          "Janus kinase 1"
        ],
        [
          "filgotinib"
        ],
        [
          "tofaci"
        ],
        [
          "tofacitin"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c7039207c78d69471000065"
    },
    {
      "exact_answer": [
        [
          "Pilocytic astrocytoma"
        ],
        [
          "Pilocytic astrocytoma (PA)"
        ],
        [
          "Pilocytic astrocytoma (PA"
        ],
        [
          "PA)"
        ],
        [
          "Pilocytic astrocytoma (PA) is the most common glioma"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6bec987c78d69471000033"
    },
    {
      "exact_answer": [
        [
          "Periodic leaf-movement"
        ],
        [
          "Periodic leaf-movement of legumes"
        ],
        [
          "leaf-movement"
        ],
        [
          "circadian leaf movement"
        ],
        [
          "Period"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c54d1a207647bbc4b000007"
    },
    {
      "exact_answer": [
        [
          "heterozygous loss-of-function variants in NFKB1"
        ],
        [
          "heterozygous loss-of-function variants"
        ],
        [
          "NFKB1"
        ],
        [
          "loss-of-function variants in NFKB1"
        ],
        [
          "loss-of-function variants"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c629937e842deac67000008"
    },
    {
      "exact_answer": [
        [
          "malformations of the eye"
        ],
        [
          "the malformations of the eye"
        ],
        [
          "malformations of the eye, referring to a congenital absence, and a reduced size of the eyeball"
        ],
        [
          "the malformations of the eye, referring to a congenital absence, and a reduced size of the eyeball"
        ],
        [
          "malformations of the eye,"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c674c287c78d6947100001a"
    },
    {
      "exact_answer": [
        [
          "pembrolizumab"
        ],
        [
          "TRK kinases"
        ],
        [
          "TRK"
        ],
        [
          "LOXO-101), Loxooncology's oral, potent, and selective inhibitor of tropomyosin receptor kinases"
        ],
        [
          "potent, and selective inhibitor of tropomyosin receptor kinases (TRK)"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c6e0f537c78d6947100004a"
    },
    {
      "exact_answer": [
        [
          "Porphyromonas gingivalis or Treponema denticola"
        ],
        [
          "Porphyromonas gingivalis"
        ],
        [
          "Treponema denticola"
        ],
        [
          "P. gingivalis"
        ],
        [
          "spirochetes family and on periodontal pathogens such as Porphyromonas gingivalis"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c53191a7e3cb0e231000016"
    },
    {
      "exact_answer": [
        [
          "2.7%"
        ],
        [
          "2.7"
        ],
        [
          "(2.7%"
        ],
        [
          "2.7%)"
        ],
        [
          "1 in 38 healthy individuals (2.7%"
        ]
      ],
      "type": "factoid",
      "ideal_answer": [
        "Dummy"
      ],
      "id": "5c51fe8907ef653866000007"
    },
    {"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c663c547c78d69471000014"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6d8f4c7c78d6947100003f"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c53143b7e3cb0e231000013"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c663e277c78d69471000015"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6d97497c78d69471000040"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c5317e77e3cb0e231000015"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6641ea7c78d69471000016"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6da11e7c78d69471000042"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6b78b77c78d69471000028"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c65484ee842deac6700001f"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6b7a9e7c78d69471000029"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c51f16307ef653866000003"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c65495be842deac67000021"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c536c427e3cb0e23100001d"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6b7bee7c78d6947100002a"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c51f44c07ef653866000004"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c54d00e07647bbc4b000005"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6b82a17c78d6947100002f"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c52028807ef653866000009"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c57216e07647bbc4b000018"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6df86b7c78d69471000045"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c5723a007647bbc4b000019"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6dfba77c78d69471000046"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c52c8b07e3cb0e23100000c"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c5f2cef1a4c55d80b000022"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c52cde87e3cb0e23100000e"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c5f39011a4c55d80b000027"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c5410647e3cb0e23100001e"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6e12247c78d6947100004b"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6bedd57c78d69471000034"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6d441d7c78d69471000037"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6f0ebf7c78d69471000050"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6dbda27c78d69471000044"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c56c5e107647bbc4b000012"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c6ffc5b7c78d69471000057"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6f15577c78d69471000053"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c71648b7c78d69471000067"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6f6ae37c78d69471000054"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c5839e707647bbc4b00001f"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c6f6d997c78d69471000055"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c58db1386df2b9174000014"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c5b2f4b1a4c55d80b000001"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c5b52731a4c55d80b000003"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c72b4897c78d69471000071"},
{"exact_answer": "Dummy", "ideal_answer": "Dummy", "type": "summary", "id": "5c608f0cc01990ff41000003"},
{"exact_answer": "yes", "ideal_answer": "Dummy", "type": "yesno", "id": "5c72ba807c78d69471000076"}
  ]
}
